|
English
|
正體中文
|
简体中文
|
2815509
|
|
???header.visitor??? :
27488445
???header.onlineuser??? :
604
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"kulp sk"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺北醫學大學 |
2014 |
AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt-MDM2-Foxo3a Signaling Axis
|
Chou, CC;Lee, KH;Lai, IL;Wang, D;Kulp, SK;Shapiro, CL;Chen, CS |
| 國家衛生研究院 |
2012-10-12 |
Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent
|
Wei, S;Chu, PC;Chuang, HC;Hung, WC;Kulp, SK;Chen, CS |
| 國家衛生研究院 |
2007-06-01 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-03 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國家衛生研究院 |
2006-09-01 |
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer
|
Kulp, SK; Chen, CS; Wang, DS; Chen, CY; Chen, CS |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
